Suchergebnisse - "Guzauskas, Gregory F"

PubPharm (3)

1

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

enthalten in: Leukemia & lymphoma | 2019

von Guzauskas, G. | Masaquel, A. | Thuresson, P. | +2

2

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

enthalten in: Journal of medical economics | 2018

von Guzauskas, G. | Masaquel, A. | Reyes, C. | +3

3

What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2017

von Guzauskas, G. | Chen, E. | Lalla, D. | +3

1
[1]